832 related articles for article (PubMed ID: 27430240)
21. Oxidized low-density lipoproteins enhance expression and activity of CD39 and CD73 in the human aortic valve endothelium.
Kaniewska-Bednarczuk E; Mielcarek M; Chester AH; Slominska EM; Yacoub MH; Smolenski RT
Nucleosides Nucleotides Nucleic Acids; 2016 Dec; 35(10-12):713-719. PubMed ID: 27906627
[TBL] [Abstract][Full Text] [Related]
22. CD39/CD73/A2a Adenosine Metabolic Pathway: Targets for Moxibustion in Treating DSS-Induced Ulcerative Colitis.
Zhu Y; Zhuang Z; Wu Q; Lin S; Zhao N; Zhang Q; Xie L; Yu S
Am J Chin Med; 2021; 49(3):661-676. PubMed ID: 33683190
[TBL] [Abstract][Full Text] [Related]
23. Adenosine and inflammation: CD39 and CD73 are critical mediators in LPS-induced PMN trafficking into the lungs.
Reutershan J; Vollmer I; Stark S; Wagner R; Ngamsri KC; Eltzschig HK
FASEB J; 2009 Feb; 23(2):473-82. PubMed ID: 18838482
[TBL] [Abstract][Full Text] [Related]
24. The role of the CD39-CD73-adenosine pathway in liver disease.
Wang S; Gao S; Zhou D; Qian X; Luan J; Lv X
J Cell Physiol; 2021 Feb; 236(2):851-862. PubMed ID: 32648591
[TBL] [Abstract][Full Text] [Related]
25. CD39 limits P2X7 receptor inflammatory signaling and attenuates sepsis-induced liver injury.
Savio LEB; de Andrade Mello P; Figliuolo VR; de Avelar Almeida TF; Santana PT; Oliveira SDS; Silva CLM; Feldbrügge L; Csizmadia E; Minshall RD; Longhi MS; Wu Y; Robson SC; Coutinho-Silva R
J Hepatol; 2017 Oct; 67(4):716-726. PubMed ID: 28554875
[TBL] [Abstract][Full Text] [Related]
26. Adenosine Generated by Regulatory T Cells Induces CD8
Shi L; Feng M; Du S; Wei X; Song H; Yixin X; Song J; Wenxian G
Biomed Res Int; 2019; 2019():4093214. PubMed ID: 31930120
[TBL] [Abstract][Full Text] [Related]
27. Intestinal immunopathology is associated with decreased CD73-generated adenosine during lethal infection.
Francois V; Shehade H; Acolty V; Preyat N; Delrée P; Moser M; Oldenhove G
Mucosal Immunol; 2015 Jul; 8(4):773-84. PubMed ID: 25389034
[TBL] [Abstract][Full Text] [Related]
28. Adenosine production by human B cells and B cell-mediated suppression of activated T cells.
Saze Z; Schuler PJ; Hong CS; Cheng D; Jackson EK; Whiteside TL
Blood; 2013 Jul; 122(1):9-18. PubMed ID: 23678003
[TBL] [Abstract][Full Text] [Related]
29. High-dimensional analysis of the adenosine pathway in high-grade serous ovarian cancer.
Bareche Y; Pommey S; Carneiro M; Buisseret L; Cousineau I; Thebault P; Chrobak P; Communal L; Allard D; Robson SC; Mes-Masson AM; Provencher D; Lapointe R; Stagg J
J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33771891
[TBL] [Abstract][Full Text] [Related]
30. Roles of the adenosine receptor and CD73 in the regulatory effect of γδ T cells.
Liang D; Zuo A; Shao H; Chen M; Kaplan HJ; Sun D
PLoS One; 2014; 9(9):e108932. PubMed ID: 25268760
[TBL] [Abstract][Full Text] [Related]
31. CD73 and CD39 ectonucleotidases in T cell differentiation: Beyond immunosuppression.
Bono MR; Fernández D; Flores-Santibáñez F; Rosemblatt M; Sauma D
FEBS Lett; 2015 Nov; 589(22):3454-60. PubMed ID: 26226423
[TBL] [Abstract][Full Text] [Related]
32. Increased ectonucleotidase expression and activity in regulatory T cells of patients with head and neck cancer.
Mandapathil M; Szczepanski MJ; Szajnik M; Ren J; Lenzner DE; Jackson EK; Gorelik E; Lang S; Johnson JT; Whiteside TL
Clin Cancer Res; 2009 Oct; 15(20):6348-57. PubMed ID: 19825957
[TBL] [Abstract][Full Text] [Related]
33. Elevated CD39+T-Regulatory Cells and Reduced Levels of Adenosine Indicate a Role for Tolerogenic Signals in the Progression from Moderate to Severe COVID-19.
Elsaghir A; El-Sabaa EMW; Zahran AM; Mandour SA; Salama EH; Aboulfotuh S; El-Morshedy RM; Tocci S; Mandour AM; Ali WE; Abdel-Wahid L; Sayed IM; El-Mokhtar MA
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139439
[TBL] [Abstract][Full Text] [Related]
34. Regulation of the T Cell Response by CD39.
Takenaka MC; Robson S; Quintana FJ
Trends Immunol; 2016 Jul; 37(7):427-439. PubMed ID: 27236363
[TBL] [Abstract][Full Text] [Related]
35. Resident cardiac immune cells and expression of the ectonucleotidase enzymes CD39 and CD73 after ischemic injury.
Bönner F; Borg N; Burghoff S; Schrader J
PLoS One; 2012; 7(4):e34730. PubMed ID: 22514659
[TBL] [Abstract][Full Text] [Related]
36. A novel mechanism of B cell-mediated immune suppression through CD73 expression and adenosine production.
Kaku H; Cheng KF; Al-Abed Y; Rothstein TL
J Immunol; 2014 Dec; 193(12):5904-13. PubMed ID: 25392527
[TBL] [Abstract][Full Text] [Related]
37. The abnormal function of CD39
Lu Y; Cheng L; Li F; Ji L; Shao X; Wu B; Zhan Y; Liu C; Min Z; Ke Y; Sun L; Chen H; Cheng Y
Ann Hematol; 2019 Aug; 98(8):1845-1854. PubMed ID: 31154474
[TBL] [Abstract][Full Text] [Related]
38. Extracellular generation of adenosine by the ectonucleotidases CD39 and CD73 promotes dermal fibrosis.
Fernández P; Perez-Aso M; Smith G; Wilder T; Trzaska S; Chiriboga L; Franks A; Robson SC; Cronstein BN; Chan ESL
Am J Pathol; 2013 Dec; 183(6):1740-1746. PubMed ID: 24266925
[TBL] [Abstract][Full Text] [Related]
39. CD73 on T Cells Orchestrates Cardiac Wound Healing After Myocardial Infarction by Purinergic Metabolic Reprogramming.
Borg N; Alter C; Görldt N; Jacoby C; Ding Z; Steckel B; Quast C; Bönner F; Friebe D; Temme S; Flögel U; Schrader J
Circulation; 2017 Jul; 136(3):297-313. PubMed ID: 28432149
[TBL] [Abstract][Full Text] [Related]
40. Enzymes of the purinergic signaling system exhibit diverse effects on the degeneration of valvular interstitial cells in a 3-D microenvironment.
Weber A; Barth M; Selig JI; Raschke S; Dakaras K; Hof A; Hesse J; Schrader J; Lichtenberg A; Akhyari P
FASEB J; 2018 Aug; 32(8):4356-4369. PubMed ID: 29558203
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
